Redpoint Bio Corporation, formerly known as Linguagen, is headquartered in New Jersey. Redpoint Bio was founded by Robert Margolskee in 1995. This biotechnology firm identifies and develops taste enhancers and blockers to improve the taste of pharmaceutical, food, and beverage products. Redpoint Bio's bitter blockers and flavor enhancers reduce the need for excess sugar and salt and contribute to the development of healthier, better tasting foods, beverages, and pharmaceutical products. Redpoint Bio's food and beverage program is focused on identifying flavor enhancers that improve the taste of existing ingredients. The pharmaceutical program uses a biochemical approach to suppress the bitterness of medicines. The company launched Spice Matrix (TM) program and TRPM5 flavor enhancers to increase the taste of spices used in food products. Redpoint Bio has made advancements in sensory science and established an integrated platform of molecular biology, biochemistry, pharmacology, high throughput screening, electrophysiology, cheminformatics, transgenic/operant animal models, sensory testing, and regulatory affairs. The major research and technology development partners of Redpoint Bio are Vernier and Coca-Cola. Redpoint Bio is a public company and its stocks are traded on over the counter bulletin board (OTCBB) under the ticker symbol OTCBB: RPBC. Redpoint Bio can be located on the Web at www.redpointbio.com.